Joseph D. Lyon
Chief Accounting Officer
Corcept Therapeutics Inc (CORT)Equibles does not estimate personal net worth.
Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get CORT alertsAbout Joseph D. Lyon
Joseph D. Lyon is recorded as Chief Accounting Officer at Corcept Therapeutics Inc (CORT). The newest filing on record that lists Joseph D. Lyon as Chief Accounting Officer at Corcept Therapeutics Inc (CORT) is dated April 14, 2023. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.
Affiliation history
-
Corcept Therapeutics Inc (CORT)
Proxy statement
CurrentStart not stated–present
Last confirmed April 17, 2026
-
Current
Start not stated–present
Last confirmed April 14, 2023
Company network
Leadership on record at Corcept Therapeutics Inc
- Joseph K. Belanoff CEO, Board Member
- James N. Wilson Chairman, Board Member
- Atabak Mokari CFO
- Joshua M. Murray CFO, Head of Investor Relations, Board Member
- Daniel N. Swisher COO
- J.D. Lyon Chief Accounting Officer
- Daniel N. Swisher, Jr. Board Member
- David L. Mahoney Board Member
- G. Leonard Baker, Jr. Board Member
- Gillian M. Cannon, PhD Board Member
Recent activity
No call appearances or filed executive changes recorded yet.